KFDA approves new type 2 diabetic agent
Developed by Bristol-Myers Squibb Company and AstraZeneca, Onglyza is indicated as an adjunct to diet and exercise to improve blood sugar (glycemic) control in ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
